Back in the ‘90s there were several reports of serious interactions in people who used Ginkgo biloba with other “blood thinners” to treat peripheral vascular disease (ie, dementia and claudication).
Researchers at the National University Hospital, in Singapore, studied the association between taking long chain omega-3 polyunsaturated fatty acid supplements and cognitive decline in an older Chinese. Continue reading Omega-3 and the risk of dementia→
Researchers at Harvard Medical School, in Boston, examined the effect of taking folic acid, vitamin B-12, and vitamin B-6 on cognitive change in women with cardiovascular disease or risk factors cardiovascular disease. Continue reading B vitamins and the risk of dementia→
A couple of years ago, researchers at the University of Florence, in Italy, reviewed the effects of the Mediterranean diet on the risk of death and the occurrence of Parkinson’s or Alzheimer’s diseases.
One hundred years ago, German physician Alois Alzheimer described “eine eigenartige Erkrankung der Hirnrinde” (a peculiar disease of the cerebral cortex) in Auguste Deter, a 51-year-old woman who had severe memory, language, and behavior problems. His autopsy results revealed a dramatically shrunken brain and unusual abnormalities in and around brain cells (shown here in black).
Products derived from the black chokeberry, Aronia melanocarpa, are claimed to be beneficial in disorders or diseases associated with oxidative stress. But these claims are based primarily on laboratory and animal research.